185 related articles for article (PubMed ID: 22068818)
1. DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma.
Brait M; Maldonado L; Begum S; Loyo M; Wehle D; Tavora FF; Looijenga LH; Kowalski J; Zhang Z; Rosenbaum E; Halachmi S; Netto GJ; Hoque MO
Br J Cancer; 2012 Jan; 106(2):414-23. PubMed ID: 22068818
[TBL] [Abstract][Full Text] [Related]
2. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
[TBL] [Abstract][Full Text] [Related]
3. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
Ahmad F; Surve P; Natarajan S; Patil A; Pol S; Patole K; Das BR
Cancer Genet; 2020 Feb; 241():42-50. PubMed ID: 31653608
[TBL] [Abstract][Full Text] [Related]
4. Differences in global DNA methylation of testicular seminoma are not associated with changes in histone modifications, clinical prognosis, BRAF mutations or gene expression.
Pedersen LH; Nielsen JE; Daugaard G; Hansen TV; Rajpert-De Meyts E; Almstrup K
Cancer Genet; 2016 Nov; 209(11):506-514. PubMed ID: 27886677
[TBL] [Abstract][Full Text] [Related]
5. Comparing genome-scale DNA methylation and CNV marks between adult human cultured ITGA6+ testicular cells and seminomas to assess in vitro genomic stability.
Struijk RB; Dorssers LCJ; Henneman P; Rijlaarsdam MA; Venema A; Jongejan A; Mannens MMAM; Looijenga LHJ; Repping S; van Pelt AMM
PLoS One; 2020; 15(3):e0230253. PubMed ID: 32176716
[TBL] [Abstract][Full Text] [Related]
6. Frequent epigenetic inactivation of p53 target genes in seminomatous and nonseminomatous germ cell tumors.
Christoph F; Kempkensteffen C; Weikert S; Krause H; Schostak M; Miller K; Schrader M
Cancer Lett; 2007 Mar; 247(1):137-42. PubMed ID: 16697107
[TBL] [Abstract][Full Text] [Related]
7. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1).
Lind GE; Skotheim RI; Fraga MF; Abeler VM; Esteller M; Lothe RA
J Pathol; 2006 Dec; 210(4):441-9. PubMed ID: 17029216
[TBL] [Abstract][Full Text] [Related]
8. Predicting metastasized seminoma using gene expression.
Ruf CG; Linbecker M; Port M; Riecke A; Schmelz HU; Wagner W; Meineke V; Abend M
BJU Int; 2012 Jul; 110(2 Pt 2):E14-20. PubMed ID: 22243760
[TBL] [Abstract][Full Text] [Related]
9. Distinctive epigenetic phenotype of cancer testis antigen genes among seminomatous and nonseminomatous testicular germ-cell tumors.
Zhang C; Kawakami T; Okada Y; Okamoto K
Genes Chromosomes Cancer; 2005 May; 43(1):104-12. PubMed ID: 15672408
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of chromatin modifications in testicular spermatocytic seminoma point toward an epigenetically unstable phenotype.
Kristensen DG; Mlynarska O; Nielsen JE; Jacobsen GK; Rajpert-De Meyts E; Almstrup K
Cancer Genet; 2012 Sep; 205(9):425-31. PubMed ID: 22819380
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing epigenetic features of preneoplastic testis tissues adjacent to seminomas and nonseminomas.
Gainetdinov IV; Kondratieva SA; Skvortsova YV; Zinovyeva MV; Stukacheva EA; Klimov A; Tryakin AA; Azhikina TL
Oncotarget; 2016 Apr; 7(16):22439-47. PubMed ID: 26843623
[TBL] [Abstract][Full Text] [Related]
13. cfDNA methylation in liquid biopsies as potential testicular seminoma biomarker.
Raos D; Oršolić D; Mašić S; Tomić M; Krasić J; Tomašković I; Gabaj NN; Gelo N; Kaštelan Ž; Kuliš T; Bojanac AK; Barešić A; Ulamec M; Ježek D; Sincic N
Epigenomics; 2022 Dec; 14(23):1493-1507. PubMed ID: 36722130
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of genes in testicular embryonal carcinomas.
Cheung HH; Yang Y; Lee TL; Rennert O; Chan WY
Br J Cancer; 2016 Jan; 114(2):230-6. PubMed ID: 26625006
[TBL] [Abstract][Full Text] [Related]
15. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors.
Smiraglia DJ; Szymanska J; Kraggerud SM; Lothe RA; Peltomäki P; Plass C
Oncogene; 2002 May; 21(24):3909-16. PubMed ID: 12032829
[TBL] [Abstract][Full Text] [Related]
16. Methylation gene
Chen S; Xiao L; Peng H; Wang Z; Xie J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 34105734
[TBL] [Abstract][Full Text] [Related]
17. Sperm imprinting integrity in seminoma patients?
Bruno C; Blagoskonov O; Barberet J; Guilleman M; Daniel S; Tournier B; Binquet C; Choux C; Fauque P
Clin Epigenetics; 2018 Oct; 10(1):125. PubMed ID: 30340650
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-beta expression in human testicular germ cell tumors.
Pais V; Leav I; Lau KM; Jiang Z; Ho SM
Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
[TBL] [Abstract][Full Text] [Related]
19. Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors.
De Jong J; Weeda S; Gillis AJ; Oosterhuis JW; Looijenga LH
Oncol Rep; 2007 Jul; 18(1):127-32. PubMed ID: 17549357
[TBL] [Abstract][Full Text] [Related]
20. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.
Cutcutache I; Suzuki Y; Tan IB; Ramgopal S; Zhang S; Ramnarayanan K; Gan A; Lee HH; Tay ST; Ooi A; Ong CK; Bolthouse JT; Lane BR; Anema JG; Kahnoski RJ; Tan P; Teh BT; Rozen SG
Eur Urol; 2015 Jul; 68(1):77-83. PubMed ID: 25597018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
